Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abaxis Inc (NASDAQ:ABAX)

45.84
Delayed Data
As of May 24
 +1.74 / +3.95%
Today’s Change
37.71
Today|||52-Week Range
58.15
-17.67%
Year-to-Date
Abaxis (ABAX) Posts Solid Q4 amid International Headwind
7:38am / Zacks.com - Paid Partner Content
New Strong Sell Stocks for May 12th
May 12 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close44.10
Today’s open44.51
Day’s range44.06 - 46.04
Volume174,525
Average volume (3 months)239,436
Market cap$1.0B
Dividend yield1.05%
Data as of 05/24/2016

Growth & Valuation

Earnings growth (last year)+57.46%
Earnings growth (this year)+1.76%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+8.05%
P/E ratio39.5
Price/Sales4.74
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NVCRNovocure Ltd-0.13-1.13%
ELGXEndologix Inc+0.16+1.35%
BABYNatus Medical Inc+1.05+3.23%
INGNInogen Inc+1.81+3.98%
Data as of 05/24/2016

Financials

Next reporting dateJuly 21, 2016
EPS forecast (this quarter)$0.33
Annual revenue (last year)$218.9M
Annual profit (last year)$31.1M
Net profit margin14.20%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Clinton H. Severson
President &
Chief Operating Officer
Donald Peter Wood
Corporate headquarters
Union City, California

Forecasts

Partner Offers

Search for Jobs